For this 4/20 enjoy FREE GROUND SHIPPING on all inventory orders, use code: Blinc420
Our sources in China have revealed that the Chinese government has just allowed three daughter companies of the pharmaceutical group Zhejiang Kangenbei from the Yunnan province to cultivate Cannabis for therapeutic use. They will be producing CBD from low THC plant varieties. This is an exclusive story from our partner in Europe, France Le Cannabiste.
From www.lecannabiste.com
Over the last weeks a new Cannabis-cooking phenomenon is rolling in over the Netflix screens, cheered by an overall happy audience. To be completely honest, we’ve really enjoyed watching it at Le Cannabiste.
When it comes to most things, many humans are conditioned to think that if a little is good, then more must be great. While in some cases that may be true, there are cases where that certainly isn’t the case. When many cannabis cultivators tried breeding high-THC strains since the early 1980s in search of that ultimate Cheech and Chong-inspired high, they ultimately bred plants that had THC percentages as high as 30% while breeding out a cannabinoid that we have only just recently come to see for its value: CBD.
Raphael Mechoulam is not a breeder or a seedbank owner, Mechoulam is not either a grower, a businessman or Cannabis advocate, as a matter of fact, the professor does not even use the Cannabis plant himself.
SHOP
EXPLORE
CONNECT
CUSTOMER SERVICE
E-MAIL BY DEPARTMENT
Privacy Policy  |  Terms of Use
Copyright © 2023 The Blinc Group, Inc. All rights reserved.
